Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 2/20 | 0.40 |
| ▸ | DDO | Q99489 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 2/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | B3GNT2 | Q9NY97 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL542484 | 0.71 | LMNA (0.70) | PTGER3LMNATNKSMAPTALDH1A1 | |
| SCHEMBL7601873 | 0.70 | HRH4 (0.37) | BRD4LMNADAODDOKDR | |
| SCHEMBL6096901 | 0.69 | AOC3 (0.44) | BRD4DAODDOFLT3CYP2A6 | |
| SCHEMBL4384462 | 0.69 | ALDH1A1 (0.59) | LMNATNKSMAPTALDH1A1 | |
| SCHEMBL542865 | 0.69 | ALDH1A1 (0.59) | LMNATNKSMAPTALDH1A1 | |
| SCHEMBL4384456 | 0.69 | ALDH1A1 (0.59) | LMNATNKSMAPTALDH1A1 | |
| SCHEMBL542713 | 0.68 | PTGER3 (0.49) | PTGER3LMNATNKSKDM4EMAPT | |
| SCHEMBL7631274 | 0.68 | LMNA (0.57) | PTGER3LMNATNKSCYP2A6KDM4E | |
| SCHEMBL13948374 | 0.68 | PTGER3 (0.46) | PTGER3LMNATNKS | |
| SCHEMBL79379 | 0.68 | LMNA (0.57) | PTGER3LMNATNKSCYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772513-B | D-carbamyl hydrolase mutant, gene, expression vector and application thereof | 江南大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-115772513-B | D-carbamyl hydrolase mutant, gene, expression vector and application thereof | 江南大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-114686464-B | Application of D-N-carbamyl hydrolase in production of D-tryptophan | 湖南引航生物科技有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-1188826-B1 | 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids | AJINOMOTO KK (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-7582454-B2 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | AJINOMOTO CO. INC. (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20060246553-A1 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | AJINOMOTO CO., INC. (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7112431-B2 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | AJINOMOTO CO. INC. (JP) | 2006-09-26 | — | — | US | disclosed |
| US-20050084946-A1 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | AJINOMOTO CO., INC. (JP) | 2005-04-21 | — | — | US | disclosed |
| US-6815195-B2 | NUCLEOTIDE SEQUENCES CODING PREFERENTIAL PROTEIN FOR USE IN GENERATING RACEMIC AMINO ACIDS | AJINOMOTO CO. INC. (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20020102713-A1 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | AJINOMOTO CO., INC. (JP) | 2002-08-01 | — | — | US | disclosed |
| EP-1188826-A2 | 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids | Ajinomoto Co., Inc. (JP) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050084946-A1 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | HDHD5, HAAO, MTAP | PTGER3 4018/4885BRD4 4820/4885LMNA 2166/4885 |
| US-20020102713-A1 | 5-substituted hydantoin racemase, DNA coding for the racemase, and processes for producing optically active amino acids | HDHD5, HAAO, MTAP | PTGER3 4018/4885BRD4 4820/4885LMNA 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.